Mercator Medical (Poland) Performance
| MRC Stock | 47.45 0.45 0.96% |
The company secures a Beta (Market Risk) of -0.0842, which conveys not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Mercator Medical are expected to decrease at a much lower rate. During the bear market, Mercator Medical is likely to outperform the market. At this point, Mercator Medical has a negative expected return of -0.27%. Please make sure to verify Mercator Medical's skewness, as well as the relationship between the rate of daily change and price action indicator , to decide if Mercator Medical performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Mercator Medical SA has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in December 2024. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors. ...more
| Begin Period Cash Flow | 399.8 M | |
| Total Cashflows From Investing Activities | -230 M |
Mercator |
Mercator Medical Relative Risk vs. Return Landscape
If you would invest 5,770 in Mercator Medical SA on September 1, 2024 and sell it today you would lose (1,025) from holding Mercator Medical SA or give up 17.76% of portfolio value over 90 days. Mercator Medical SA is generating negative expected returns and assumes 2.8815% volatility on return distribution over the 90 days horizon. Simply put, 25% of stocks are less volatile than Mercator, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Mercator Medical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Mercator Medical's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Mercator Medical SA, and traders can use it to determine the average amount a Mercator Medical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0937
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | MRC |
Estimated Market Risk
| 2.88 actual daily | 25 75% of assets are more volatile |
Expected Return
| -0.27 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.09 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Mercator Medical is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Mercator Medical by adding Mercator Medical to a well-diversified portfolio.
Mercator Medical Fundamentals Growth
Mercator Stock prices reflect investors' perceptions of the future prospects and financial health of Mercator Medical, and Mercator Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Mercator Stock performance.
| Return On Equity | 0.0179 | |||
| Return On Asset | -0.0044 | |||
| Profit Margin | 0.03 % | |||
| Operating Margin | (0.01) % | |||
| Current Valuation | 35.23 M | |||
| Shares Outstanding | 9.77 M | |||
| Price To Book | 0.40 X | |||
| Price To Sales | 0.60 X | |||
| Revenue | 1.73 B | |||
| EBITDA | 498.66 M | |||
| Book Value Per Share | 112.72 X | |||
| Cash Flow From Operations | 503 M | |||
| Earnings Per Share | 2.63 X | |||
| Total Asset | 1.29 B | |||
About Mercator Medical Performance
Assessing Mercator Medical's fundamental ratios provides investors with valuable insights into Mercator Medical's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Mercator Medical is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Things to note about Mercator Medical performance evaluation
Checking the ongoing alerts about Mercator Medical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Mercator Medical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Mercator Medical generated a negative expected return over the last 90 days | |
| Mercator Medical has high likelihood to experience some financial distress in the next 2 years | |
| About 64.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing Mercator Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Mercator Medical's stock is overvalued or undervalued compared to its peers.
- Examining Mercator Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Mercator Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Mercator Medical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Mercator Medical's stock. These opinions can provide insight into Mercator Medical's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Mercator Stock Analysis
When running Mercator Medical's price analysis, check to measure Mercator Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mercator Medical is operating at the current time. Most of Mercator Medical's value examination focuses on studying past and present price action to predict the probability of Mercator Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mercator Medical's price. Additionally, you may evaluate how the addition of Mercator Medical to your portfolios can decrease your overall portfolio volatility.